{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:41:27Z","timestamp":1789904487904,"version":"4.0.1"},"reference-count":37,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,1,12]],"date-time":"2009-01-12T00:00:00Z","timestamp":1231718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Science"],"published-print":{"date-parts":[[2009,4]]},"abstract":"<jats:p>\n                    L\u2010[3\u2010\n                    <jats:sup>18<\/jats:sup>\n                    F]\u2010\u03b1\u2010methyltyrosine (\n                    <jats:sup>18<\/jats:sup>\n                    F\u2010FMT) is an amino\u2010acid tracer for positron\u2010emission tomography (PET). We have conducted a clinicopathologic study to elucidate the correlation of angiogenesis with\n                    <jats:sup>18<\/jats:sup>\n                    F\u2010FMT and 2\u2010[\n                    <jats:sup>18<\/jats:sup>\n                    F]\u2010fluoro\u20102\u2010deoxy\u2010D\u2010glucose (\n                    <jats:sup>18<\/jats:sup>\n                    F\u2010FDG) uptake in patients with non\u2010small cell lung cancer (NSCLC). Thirty\u2010seven NSCLC patients were enrolled in this study, and two PET studies with\n                    <jats:sup>18<\/jats:sup>\n                    F\u2010FMT and\n                    <jats:sup>18<\/jats:sup>\n                    F\u2010FDG were performed. Uptake of PET tracers was evaluated with standardized uptake value. Vascular endothelial growth factor (VEGF), CD31, CD34, L\u2010type amino acid transporter 1 (LAT1) and Ki\u201067 labeling index of the resected tumors were analyzed by immunohistochemical staining, and correlated with the clinicopathologic variables and the uptake of PET tracers. The median VEGF rate was 45% (range, 10\u201378%). High expression was seen in 30 patients (81%, 30\/37). VEGF expression was statistically associated with progressively growing microvessel count. VEGF showed a correlation with LAT1 expression (\n                    <jats:italic>P<\/jats:italic>\n                    \u00a0=\u00a00.04) and Ki\u201067 labeling index (\n                    <jats:italic>P<\/jats:italic>\n                    \u00a0=\u00a00.01). However, it showed no correlation with age, gender, disease stage, tumor size, and histology. Microvessel density (MVD) showed no correlation with any parameters.\n                    <jats:sup>18<\/jats:sup>\n                    F\u2010FMT and\n                    <jats:sup>18<\/jats:sup>\n                    F\u2010FDG uptake correlated significantly with VEGF (\n                    <jats:italic>P<\/jats:italic>\n                    \u00a0&lt;\u00a00.0001,\n                    <jats:italic>P<\/jats:italic>\n                    \u00a0=\u00a00.026, respectively), whereas the correlation of\n                    <jats:sup>18<\/jats:sup>\n                    F\u2010FMT and VEGF was more meaningful. The present study demonstrated that the metabolic activity of primary tumors as evaluated by PET study with\n                    <jats:sup>18<\/jats:sup>\n                    F\u2010FMT and\n                    <jats:sup>18<\/jats:sup>\n                    F\u2010FDG is related to tumor angiogenesis and the proliferative activity in NSCLC. (\n                    <jats:italic>Cancer Sci<\/jats:italic>\n                    2009; 100: 753\u2013758)\n                  <\/jats:p>","DOI":"10.1111\/j.1349-7006.2008.01077.x","type":"journal-article","created":{"date-parts":[[2009,1,12]],"date-time":"2009-01-12T03:56:00Z","timestamp":1231732560000},"page":"753-758","source":"Crossref","is-referenced-by-count":48,"title":["Correlation of angiogenesis with\n                    <sup>18<\/sup>\n                    F\u2010FMT and\n                    <sup>18<\/sup>\n                    F\u2010FDG uptake in non\u2010small cell lung cancer"],"prefix":"10.1111","volume":"100","author":[{"given":"Kyoichi","family":"Kaira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noboru","family":"Oriuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimihiro","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Ishikita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisao","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Yanagitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Sunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Hisada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamotsu","family":"Ishizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikatsu","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Endou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatomo","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,3,30]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/89.12.881"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.8.2858"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(99)00327-5"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200007273430404"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.6.2142"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00841411"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002590000367"},{"key":"e_1_2_7_9_2","first-page":"39","article-title":"18F\u2010FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non\u2010small cell lung cancer","volume":"43","author":"Higashi K","year":"2002","journal-title":"J Nucl Med"},{"key":"e_1_2_7_10_2","first-page":"419","article-title":"Microvessel density: correlation with 18F\u2010FDG uptake and prognosis impact in lung adenocarcinomas","volume":"47","author":"Guo J","year":"2006","journal-title":"J Nucl Med"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.61.4.729"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-2736(02)00516-3"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.220.1.r01jl1654"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-2160"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-1294"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2005.04.005"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2186"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006231-199702000-00013"},{"key":"e_1_2_7_19_2","first-page":"457","article-title":"Independent thallium\u2010201 accumulation and fluorine\u201018\u2010fluorodeoxyglucose metabolism in glioma","volume":"37","author":"Oriuchi N","year":"1996","journal-title":"J Nucl Med"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006231-199909000-00012"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2003.013508"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199101033240101"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800587"},{"key":"e_1_2_7_24_2","first-page":"721","article-title":"Ki\u201067 immunostaining in pancreatic cancer and chronic active pancreatitis: does in vivo FDG uptake correlate with proliferative activity?","volume":"42","author":"Buck AC","year":"2001","journal-title":"J Nucl Med"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602233"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-2736(01)00384-4"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.41.28845"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21866"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-200011090-00021"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004728-200203000-00004"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.2.379"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2006.08.012"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.neo.7900133"},{"key":"e_1_2_7_34_2","first-page":"439","article-title":"Expression of 1\u2010type amino acid transporter 1 in a rat model of liver metastasis: positive correlation with tumor size","volume":"25","author":"Tamai S","year":"2001","journal-title":"Cancer Detect Prev"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0202-128"},{"key":"e_1_2_7_36_2","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1177\/030089160709300617","article-title":"18F\u2010FDG PET evaluation correlates better than CT with pathological response in a metastatic colon cancer patient treated with bevacizumab\u2010based therapy","volume":"93","author":"Funaioli C","year":"2007","journal-title":"Tumori"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.06.081"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0414"}],"container-title":["Cancer Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.2008.01077.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2008.01077.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T03:31:45Z","timestamp":1697167905000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2008.01077.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,30]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["10.1111\/j.1349-7006.2008.01077.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.2008.01077.x","archive":["Portico"],"relation":{},"ISSN":["1347-9032","1349-7006"],"issn-type":[{"value":"1347-9032","type":"print"},{"value":"1349-7006","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,30]]}}}